Anti‐rubella <scp>IgG</scp> serum levels predict risk for <scp>SARS</scp>‐<scp>CoV</scp>‐2 breakthrough infections-Reference-Cited by-同舟云学术

Anti‐rubella IgG serum levels predict risk for SARS‐CoV‐2 breakthrough infections

Published:2024-07-09 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Hollstein Moritz M.¹,Dierks Sascha²³,Schön Michael P.¹⁴,Groß Uwe³⁵,Thiele Karin²³,Leha Andreas⁶,Zautner Andreas E.⁵⁷⁸,Fischer Andreas²³,Erpenbeck Luise¹⁹,Schnelle Moritz²³^ORCID

Affiliation:

1. Department of Dermatology, Venereology and Allergology University Medical Center Göttingen Göttingen Germany

2. Department of Clinical Chemistry University Medical Center Göttingen Göttingen Germany

3. Interdisciplinary UMG Laboratory University Medical Center Göttingen Göttingen Germany

4. Lower Saxony Institute of Occupational Dermatology University Medical Center Göttingen Göttingen Germany

5. Institute of Medical Microbiology and Virology University Medical Center Göttingen Göttingen Germany

6. Department of Medical Statistics University Medical Center Göttingen Göttingen Germany

7. Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty Otto‐von‐Guericke University Magdeburg Magdeburg Germany

8. Center for Health and Medical Prevention (CHaMP) Otto‐von‐Guericke University Magdeburg Magdeburg Germany

9. Department of Dermatology University of Münster Münster Germany

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16232

Reference7 articles.

1. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

2. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

3. Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients

4. Humoral and cellular immune responses in fully vaccinated individuals with or without SARS‐CoV‐2 breakthrough infection: Results from the CoV‐ADAPT cohort

5. Association between a low response to rubella vaccination and reduced anti-severe acute respiratory syndrome coronavirus 2 immune response after vaccination with BNT162b2: a cross-sectional study